EPIAIDEA
Epidemiology · AI · Data · Evidence · Action
Consulting › Digital Epidemiology & Infodemiology
Digital Epidemiology · Infodemiology

Populations signal distress
before they reach a clinic. I read those signals.

Traditional surveillance is retrospective by construction: someone must fall ill, seek care, be diagnosed, and be reported before a case exists. That chain takes weeks. Search queries, social posts, and digital behaviour move in hours — and under the right methods they carry real epidemiologic signal.

I build and validate those systems. My published work spans COVID-19 search surveillance, global infodemic analysis, vaccine safety signal tracking, and variant monitoring through query data. I also know where this field oversells itself: digital signals are noisy, confounded by media coverage, and easy to misread. The discipline is in separating the signal from the news cycle.

Published in JMIR Public Health & Surveillance PharmD · PhD Epidemiology 100,000+ citations h-index 84 Infodemiology · Search & social surveillance

Where I Help

Surveillance · Signals · Systems

Most digital surveillance projects fail the same way: a correlation is found in historical data, declared predictive, then degrades quietly once deployed. The work that matters is validation against a real epidemiologic endpoint, and monitoring that detects decay rather than discovering it later.

Real-time surveillance systems

Monitoring built on digital data streams, validated against conventional indicators so you know what the signal is actually tracking.

  • Search query surveillance and trend modelling
  • Social and platform data for population health signals
  • Validation against case counts, claims, or syndromic data
  • Early-warning thresholds with explicit false-positive costs
  • Dashboards built for a decision, not for display

Infodemiology & misinformation

Measuring how health information and misinformation move through populations, and what that movement does to behaviour and uptake.

  • Information demand mapping during outbreaks
  • Vaccine hesitancy and safety-concern signal tracking
  • Distinguishing genuine concern from media-driven spikes
  • NLP and text mining over large corpora
  • Communication-gap analysis to target response

Signal detection & early warning

Detecting change early enough to act, while controlling the false alarms that destroy trust in a system.

  • Outbreak and anomaly detection methods
  • Drug safety signal monitoring from digital sources
  • Variant and seasonal pattern tracking
  • Explicit sensitivity and specificity trade-off design
  • Alert protocols that specify who acts and when

AI & agentic surveillance methods

Applying large language models and agentic pipelines to epidemiologic monitoring — with the validation such systems usually skip.

  • LLM-based extraction from unstructured health text
  • Automated literature and signal triage pipelines
  • Agentic workflows for continuous evidence monitoring
  • Benchmarking against expert human review
  • Drift detection and performance monitoring over time

How an Engagement Runs

01
Define the signal

We define what you need to detect, how fast, and what counts as an actionable signal — before any data is pulled.

02
Validate sources

Data sources are assessed for coverage and bias, and the signal is validated against a conventional epidemiologic endpoint.

03
Build

The system is built with documented methods and reproducible code, tuned to an agreed false-positive tolerance.

04
Monitor

Monitoring for performance decay on a defined review cadence, because a surveillance system left alone stops working.

If you are building something that watches a population, let's talk.

You don't need a formal brief to start. Describe what you are trying to detect and I'll tell you honestly whether digital data can detect it, and what it would take to trust the result.

If it isn't a fit, I'll say so directly — and where I can, point you to someone better placed. There's no obligation in asking.

in
Follow the work on LinkedIn I post analysis on health policy evidence, drug safety, and digital epidemiology — usually before it reaches a journal.